Race for weight-loss drugs intensifies with data on obesity pills
Aykut Karahan | Stock | fake images A version of this article first appeared in CNBC's Healthy Returns newsletter, bringing…
Viking Therapeutics Inc.
GLP-1s are being tested for uses beyond weight loss and diabetes
Slimming syringes of the brands “Wegovy”, “Ozempic” and “Mounjaro” are sold at In der Achat Apotheke in Mitte, Germany. Image…
These drugmakers are catching up to Eli Lilly and Novo Nordisk
The lucrative market for weight-loss drugs won’t be a duopoly forever. With billions at stake, that’s been a virtual guarantee…
Fund manager of names in weight loss and biotechnology
Weight-loss drugs have sparked investor interest and shaken up other sectors over the past year. Novo Nordisk and Eli Lilly…
Viking Therapeutics shares rise on plans to test weight-loss injection
Weight loss drug concept. Cr | Istock | Getty Images Actions of Viking Therapeutics rose more than 20% on Thursday…
Paradromics launches registry of patients with brain implants
Do you think a friend or colleague should receive this newsletter? this link with them to register. Aamir Ahmed Khan,…
Eli Lilly and drug makers show data on weight loss drugs
An injectable pen of Zepbound, Eli Lilly's weight loss drug, is on display in New York City on December 11,…
The first drug for NASH liver disease is here, with more to come
3D illustration of a human liver organ. magic mine | iStock | fake images Do you think a friend or…
Viking Therapeutics emerges as a competitor
CR | Stock | fake images biotechnology company Viking therapeutics has become a strong potential entrant (or acquisition target) in…
Here's Eli Lilly's Competitive Advantage in GLP-1 Obesity Drugs and Abbott's Supporting Role
Every weekday, the CNBC Investing Club with Jim Cramer publishes Homestretch, a helpful afternoon update just in time for the…